secwatch / observer
8-K filed March 3, 2023, 6:59 PM ET ticker AWHL CIK 0000926617
leadership confidence high sentiment neutral materiality 0.50

Aspira Women's Health appoints Dr. Jordan as Chair; Palmieri resigns as Executive Chair and director

Aspira Women's Health Inc.

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Valerie Palmieri

Executive Chair
AWHL · Aspira Women's Health Inc.
Effective
2023-03-01
Filed
March 3, 2023, 6:59 PM ET
Ms. Palmieri’s term as Executive Chair of the Company concluded on March 1, 2023.
Role change

Dr. Robert Auerbach

Lead Independent Director
AWHL · Aspira Women's Health Inc.
Effective
2023-03-01
Filed
March 3, 2023, 6:59 PM ET
Dr. Robert Auerbach stepped down as the Company’s Lead Independent Director, effective as of March 1, 2023.
Appointed

Dr. Veronica G.H. Jordan

Chair of the Board
AWHL · Aspira Women's Health Inc.
Effective
2023-03-01
Filed
March 3, 2023, 6:59 PM ET
the board of directors (the “Board”) of Aspira Women’s Health Inc. (the “Company”) appointed Dr. Veronica G.H. Jordan as the Chair of the Board , effective as of March 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Valerie Palmieri resigned as Executive Chair at Aspira Women's Health Inc..

Action
resigned
Role
Executive Chair
Exact text from the filing
Ms. Palmieri’s term as Executive Chair of the Company concluded on March 1, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.9

Dr. Robert Auerbach changed role as Lead Independent Director at Aspira Women's Health Inc..

Action
stepped down
Role
Lead Independent Director
Exact text from the filing
Dr. Robert Auerbach stepped down as the Company’s Lead Independent Director, effective as of March 1, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Veronica G.H. Jordan was appointed as Chair of the Board at Aspira Women's Health Inc..

Action
appointed
Role
Chair of the Board
Exact text from the filing
the board of directors (the “Board”) of Aspira Women’s Health Inc. (the “Company”) appointed Dr. Veronica G.H. Jordan as the Chair of the Board , effective as of March 1, 2023.
View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR
accession 0000926617-23-000016
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.